Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Int J Drug Policy. 2015 Jan 14;26(4):336–344. doi: 10.1016/j.drugpo.2015.01.009

Table 4.

Observed Prevalence of Marijuana-Related Behaviors and Attitudes among U.S. 10th and 8th Graders, by Year and California Residency (Weighted), Standard Errors in Parentheses

Marijuana Outcome ---Year---
2007 2008 2009 2010 2011 2012 2013
10th GRADE
 Past 30 day use (n=104,953)
  California .14 (.01) .13 (.01) .18* (.01) .20* (.02) .19 (.02) .17 (.02) .18 (.02)
  Not California .14 (.01) .14 (.01) .16 (.01) .16 (.01) .17 (.01) .17 (.01) .18 (.01)
 Past 12-mo use (n=104,987)
  California .25 (.01) .24 (.01) .31** (.01) .32 (.02) .30 (.02) .29 (.03) .29 (.03)
  Not California .24 (.01) .24 (.01) .26 (.01) .27 (.01) .29 (.01) .28 (.01) .30 (.01)
 Lifetime use (n=105,143)
  California .32 (.01) .30 (.02) .36** (.01) .37 (.03) .36 (.03) .35 (.03) .35 (.03)
  Not California .31 (.01) .30 (.01) .32 (.01) .33 (.01) .34 (.01) .33 (.01) .36 (.01)
 Perceived high risk of regular use (n=94,073)
  California 0.65 (.02) 0.64 (.02) 0.56* (.02) 0.56 (.02) 0.55 (.03) 0.51 (.02) 0.49 (.03)
  Not California 0.66 (.01) 0.67 (.01) 0.62 (.01) 0.59 (.01) 0.57 (.01) 0.53 (.01) 0.48 (.01)
 Strong disapproval of regular use (n=94,183)
  California 0.61 (.02) 0.62 (.02) 0.55 (.02) 0.51*(.03) 0.54 (.03) 0.53 (.02) 0.51 (.02)
  Not California 0.63 (.01) 0.63 (.01) 0.60 (.01) 0.59 (.01) 0.57 (.01) 0.56 (.01) 0.51 (.01)
 Perceived availability (n=96,405)
  California 0.74 (.02) 0.72 (.02) 0.79**(.02) 0.77 (.02) 0.75 (.03) 0.74 (.02) 0.74 (.02)
  Not California 0.73 (.01) 0.72 (.01) 0.74 (.01) 0.74 (.01) 0.73 (.01) 0.73 (.01) 0.75 (.01)
8th GRADE
 Past 30 day use (n=107,772)
  California .06 (.01) .05 (.01) .07 (.03) .09 (.02) .10 (.02) .09 (.02) .07 (.01)
  Not California .06 (.004) .06 (.004) .06 (.004) .08 (.006) .07 (.005) .06 (.005) .07 (.005)
 Past 12-mo use (n=107,814)
  California .10 (.01) .10 (.02) .12 (.04) .15 (.03) .17** (.03) .15* (.02) .13 (.02)
  Not California .10 (.01) .11 (.01) .12 (.005) .13 (.01) .12 (.01) .11 (.01) .13 (.01)
 Lifetime use (n=107,898)
  California .13 (.02) .12 (.02) .17 (.05) .19 (.03) .22*(.04) .20 (.02) .16 (.02)
  Not California .14 (.01) .15 (.01) .16 (.01) .17 (.01) .16 (.01) .15 (.01) .17 (.01)
 Perceived high risk of regular use (n=94,782)
  California 0.76 (.03) 0.70 (.04) 0.68 (.02) 0.65 (.04) 0.65 (.02) 0.61** (.03) 0.63 (.01)
  Not California 0.77(.01) 0.75 (.01) 0.73 (.01) 0.71 (.01) 0.71 (.01) 0.71 (.01) 0.64 (.01)
 Strongly disapproval of regular use (n=94,846)
  California 0.69 (.04) 0.71 (.05) 0.68 (.06) 0.65 (.04) 0.65 (.04) 0.65** (.04) 0.69 (.02)
  Not California 0.75 (.01) 0.74 (.01) 0.73 (.01) 0.70 (.01) 0.72 (.01) 0.71 (.01) 0.68 (.01)
 Perceived availability (n=92,703)
  California 0.39 (.03) 0.37 (.02) 0.41 (.06) 0.48 (.03) 0.51* (.04) 0.44 (.03) 0.45 (.02)
  Not California 0.41 (.01) 0.44 (.01) 0.44 (.01) 0.45 (.01) 0.41 (.01) 0.40 (.01) 0.43 (.01)

Note: Reported sample sizes are unweighted.

*

p<.05; prevalence significantly different among California as compared to non-California residents in this year

**

p<.01; prevalence significantly different among California as compared to non-California residents in this year